Drug policy reform advocates, public health experts and current and former government officials met for a summit in Colorado over the weekend to discuss how to move forward with state-led clinical research into ibogaine as a treatment for addiction, trauma and various neurodegenerative conditions.

Attendees at the three-day Aspen Ibogaine Meeting discussed science and policy around the plant-based psychedelic as well as how to go about building the necessary financial and legal infrastructure ...